Signaling pathways
-
BA3504 PK68Summary: PK68 is a potent and specific type II inhibitor of receptor-interacting kinase 1 (RIPK1) with oral activity. - BA3505 RIPK-IN-4Summary: RIPK-IN-4 is a potent and selective inhibitor with good oral bioavailability.
- BA3506 Necrostatin-34Summary: Necrostatin-34 (Nec-34) is an inhibitor of kinases.
- BA3507 RIPK1-IN-4Summary: RIPK1-IN-4 is a potent inhibitor of type II kinase receptor-interacting protein 1 kinase.
- BA3508 OditrasertibSummary: Oditrasertib is a receptor-interacting protein kinase 1 inhibitor with values below 100 nM.
- BA3509 HTH-01-091Summary: HTH-01-091 is a potent and selective inhibitor.
- BA3510 Zharp2-1Summary: Zharp2-1 is an orally potent RIPK2 inhibitor highly associated with inflammatory bowel disease (IBD).
- BA3511 RIPK1-IN-10Summary: An effective inhibitor.
- BA3512 SZM679Summary: SZM679 is an orally potent and selective inhibitor with values of 8.6 nM and >5000 nM for RIPK1 and RIPK3, respectively.
- BA3513 RIPK1-IN-9Summary: RIPK1-IN-9 is a dihydronaphthyridone compound, a potent and selective inhibitor.